ArticleBMC nephrology2021

Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data analysis of patients in the IMADJIN® dataset.

Mark Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.